Table 1 Patient characteristics (n = 31)
From: Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma
Characteristics | No. |
|---|---|
Gender | |
Male | 22 (71%) |
Female | 9 (29%) |
Performance status | |
0 | 17 (55%) |
1 | 12 (39%) |
2 | 2 (6%) |
Child-Pugh classification | |
A | 27 (87%) |
B | 4 (13%) |
MELD score | |
6–7 | 17 (55%) |
8–9 | 11 (35%) |
10 ≤ | 3 (10%) |
Viral marker | |
HBs-Ag (+), HCV-Ab (−) | 2 (6%) |
HBs-Ag (−), HCV-Ab (+) | 18 (58%) |
HBs-Ag (+), HCV-Ab (+) | 1 (3%) |
HBs-Ag (−), HCV-Ab (−) | 10 (33%) |
Co-morbidity | |
Diabetes mellitus | 10 (33%) |
Hypertension | 16 (52%) |
Cardiovascular disease | 8 (26%) |
Respiratory disease | 5 (16%) |
Chronic renal failure | 2 (6%) |
Brain disease | 2 (6%) |
Tumor size, mm, median [range] | 45 [15–93] |
Serum AFP level, ng/ml, median [range] | 7.3 [1.3–48,058.3] |
Serum AFP-L3, %, median [range] | 3.1 [< 0.5–84.2] |
Serum PIVKA-II level, mAU/ml, median [range] | 85 [10–19,937] |
Stage (UICC 7th edition) | |
I | 24 (77%) |
II | 4 (14%) |
III | 3 (9%) |
Stage (BCLC) | |
A | 13 (42%) |
B | 1 (3%) |
C | 17 (55%) |